Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.77 - $3.03 $26 - $45
-15 Reduced 0.09%
15,920 $44,000
Q3 2023

Oct 11, 2023

BUY
$2.87 - $4.99 $43 - $74
15 Added 0.09%
15,935 $45,000
Q2 2023

Jul 10, 2023

SELL
$1.43 - $6.18 $28,600 - $123,600
-20,000 Reduced 55.68%
15,920 $80,000
Q1 2023

Apr 14, 2023

SELL
$1.35 - $3.14 $36 - $84
-27 Reduced 0.08%
35,920 $67,000
Q4 2022

Jan 31, 2023

SELL
$1.27 - $2.51 $12 - $25
-10 Reduced 0.03%
35,947 $64,000
Q3 2022

Oct 25, 2022

SELL
$1.68 - $4.01 $719 - $1,716
-428 Reduced 1.18%
35,957 $61,000
Q2 2022

Aug 03, 2022

BUY
$1.5 - $3.63 $17,133 - $41,461
11,422 Added 45.76%
36,385 $90,000
Q1 2022

Apr 18, 2022

BUY
$2.66 - $5.61 $23,482 - $49,525
8,828 Added 54.71%
24,963 $69,000
Q4 2021

Jan 20, 2022

BUY
$5.18 - $8.48 $83,579 - $136,824
16,135 New
16,135 $86,000

Others Institutions Holding BDTX

About Black Diamond Therapeutics, Inc.


  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $99.2M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.